Port-Wine Stain Laser Treatments and Novel Approaches

Arisa E. Ortiz; J. Stuart Nelson

doi:10.1055/s-0032-1329936

Facial Plastic Surgery, Inhaltsverzeichnis

Facial Plast Surg 2012; 28(06): 611-620
DOI: 10.1055/s-0032-1329936

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Port-Wine Stain Laser Treatments and Novel Approaches

Autor*innen

Arisa E. Ortiz

¹Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
J. Stuart Nelson

²Departments of Surgery and Biomedical Engineering, Beckman Laser Institute and Medical Clinic, University of California, Irvine, Irvine, California

Abstract

Background and Objectives Port-wine stains (PWSs) are capillary vascular malformations that are commonly resistant to treatment. Currently, the pulsed dye laser (PDL) is the treatment of choice. Multiple treatments are required and complete blanching after laser irradiation is rarely achieved. We review current therapeutic modalities for PWSs and recent developments for enhanced clearance.

Study Design/Materials and Methods Relevant literature was reviewed including PDL modifications for improved efficacy, alternative laser devices for treatment-resistant PWSs, and the addition of agents to modulate the wound-healing response after laser irradiation.

Results Although PDL is the treatment of choice for PWSs, increased understanding of interactions between PWSs and PDL has led to improvements in therapeutic outcome in terms of lesion blanching.

Conclusions Preliminary evidence of combination therapy using antiangiogenic agents after laser irradiation appears promising and could lead to the development of a new standard of care for PWSs.

Keywords

port-wine stains - capillary malformation - laser - selective photothermolysis - pulsed dye laser

Volltext

Referenzen

References
1 Malm M, Carlberg M. Port-wine stain—a surgical and psychological problem. Ann Plast Surg 1988; 20: 512-516
2 Kirkland CR, Mutasim DF. Acquired port-wine stain following repetitive trauma. J Am Acad Dermatol 2011; 65: 462-463
3 Adams BB, Lucky AW. Acquired port-wine stains and antecedent trauma: case report and review of the literature. Arch Dermatol 2000; 136: 897-899
4 Schneider BV, Mitsuhashi Y, Schnyder UW. Ultrastructural observations in port wine stains. Arch Dermatol Res 1988; 280: 338-345
5 Enjolras O, Riche MC, Merland JJ. Facial port-wine stains and Sturge-Weber syndrome. Pediatrics 1985; 76: 48-51
6 Mazereeuw-Hautier J, Syed S, Harper JI. Bilateral facial capillary malformation associated with eye and brain abnormalities. Arch Dermatol 2006; 142: 994-998
7 Lindhurst MJ, Sapp JC, Teer JK , et al. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med 2011; 365: 611-619
8 Happle R. Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin. J Am Acad Dermatol 1987; 16: 899-906
9 Clodius L. Surgery for the extensive facial port-wine stain?. Aesthetic Plast Surg 1985; 9: 61-68
10 Thomson HG, Wright AM. Surgical tattooing of the port-wine stain. Operative technique, results, and critique. Plast Reconstr Surg 1971; 48: 113-120
11 Cosman B. Experience in the argon laser therapy of port wine stains. Plast Reconstr Surg 1980; 65: 119-129
12 Majaron B, Nelson JS. Laser treatment of port wine stains. In: Welch A, van Gemert M, , eds. Optical-Thermal Response of Laser-Irradiated Tissue. 2nd ed. New York, NY: Springer; 2011
13 Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983; 220: 524-527
14 Goldman MP, Fitzpatrick RE, Ruiz-Esparza J. Treatment of port-wine stains (capillary malformation) with the flashlamp-pumped pulsed dye laser. J Pediatr 1993; 122: 71-77
15 Anderson RR, Parrish JA. Microvasculature can be selectively damaged using dye lasers: a basic theory and experimental evidence in human skin. Lasers Surg Med 1981; 1: 263-276
16 Nelson JS, Milner TE, Svaasand LO, Kimel S. Laser pulse duration must match the estimated thermal relaxation time for successful photothermolysis of blood vessels. Lasers Med Sci 1995; 10: 9-12
17 Morelli JG, Tan OT, Garden J , et al. Tunable dye laser (577 nm) treatment of port wine stains. Lasers Surg Med 1986; 6: 94-99
18 Hulsbergen Henning JP, van Gemert MJ, Lahaye CT. Clinical and histological evaluation of portwine stain treatment with a microsecond-pulsed dye-laser at 577 nm. Lasers Surg Med 1984; 4: 375-380
19 Lanigan SW, Taibjee SM. Recent advances in laser treatment of port-wine stains. Br J Dermatol 2004; 151: 527-533
20 Dierickx CC, Casparian JM, Venugopalan V, Farinelli WA, Anderson RR. Thermal relaxation of port-wine stain vessels probed in vivo: the need for 1-10-millisecond laser pulse treatment. J Invest Dermatol 1995; 105: 709-714
21 Nelson JS, Milner TE, Anvari B , et al. Dynamic epidermal cooling during pulsed laser treatment of port-wine stain. A new methodology with preliminary clinical evaluation. Arch Dermatol 1995; 131: 695-700
22 Raulin C, Greve B, Hammes S. Cold air in laser therapy: first experiences with a new cooling system. Lasers Surg Med 2000; 27: 404-410
23 Nelson JS, Milner TE, Anvari B, Tanenbaum BS, Svaasand LO, Kimel S. Dynamic epidermal cooling in conjunction with laser-induced photothermolysis of port wine stain blood vessels. Lasers Surg Med 1996; 19: 224-229
24 Katugampola GA, Lanigan SW. Five years' experience of treating port wine stains with the flashlamp-pumped pulsed dye laser. Br J Dermatol 1997; 137: 750-754
25 Nelson JS, Geronemus RG. Redarkening of port-wine stains 10 years after laser treatment. N Engl J Med 2007; 356: 2745-2746 ; author reply 2746
26 Renfro L, Geronemus RG. Anatomical differences of port-wine stains in response to treatment with the pulsed dye laser. Arch Dermatol 1993; 129: 182-188
27 Chapas AM, Eickhorst K, Geronemus RG. Efficacy of early treatment of facial port wine stains in newborns: a review of 49 cases. Lasers Surg Med 2007; 39: 563-568
28 Nguyen CM, Yohn JJ, Huff C, Weston WL, Morelli JG. Facial port wine stains in childhood: prediction of the rate of improvement as a function of the age of the patient, size and location of the port wine stain and the number of treatments with the pulsed dye (585 nm) laser. Br J Dermatol 1998; 138: 821-825
29 Selim MM, Kelly KM, Nelson JS, Wendelschafer-Crabb G, Kennedy WR, Zelickson BD. Confocal microscopy study of nerves and blood vessels in untreated and treated port wine stains: preliminary observations. Dermatol Surg 2004; 30: 892-897
30 Barsky SH, Rosen S, Geer DE, Noe JM. The nature and evolution of port wine stains: a computer-assisted study. J Invest Dermatol 1980; 74: 154-157
31 Fiskerstrand EJ, Svaasand LO, Kopstad G, Dalaker M, Norvang LT, Volden G. Laser treatment of port wine stains: therapeutic outcome in relation to morphological parameters. Br J Dermatol 1996; 134: 1039-1043
32 Hohenleutner U, Hilbert M, Wlotzke U, Landthaler M. Epidermal damage and limited coagulation depth with the flashlamp-pumped pulsed dye laser: a histochemical study. J Invest Dermatol 1995; 104: 798-802
33 Jia W, Choi B, Franco W , et al. Treatment of cutaneous vascular lesions using multiple-intermittent cryogen spurts and two-wavelength laser pulses: numerical and animal studies. Lasers Surg Med 2007; 39: 494-503
34 Bencini PL. The multilayer technique: a new and fast approach for flashlamp-pumped pulsed (FLPP) dye laser treatment of port-wine stains (preliminary reports). Dermatol Surg 1999; 25: 786-789
35 Lorenz S, Brunnberg S, Landthaler M, Hohenleutner U. Regarding the multilayer technique for treatment of PWS. Dermatol Surg 2001; 27: 90
36 Verkruysse W, van Gemert MJ, Smithies DJ, Nelson JS. Modelling multiple laser pulses for port wine stain treatment. Phys Med Biol 2000; 45: N197-N203
37 Yang MU, Yaroslavsky AN, Farinelli WA , et al. Long-pulsed neodymium:yttrium-aluminum-garnet laser treatment for port-wine stains. J Am Acad Dermatol 2005; 52 (3 Pt 1) 480-490
38 Izikson L, Nelson JS, Anderson RR. Treatment of hypertrophic and resistant port wine stains with a 755 nm laser: a case series of 20 patients. Lasers Surg Med 2009; 41: 427-432
39 Chowdhury MM, Harris S, Lanigan SW. Potassium titanyl phosphate laser treatment of resistant port-wine stains. Br J Dermatol 2001; 144: 814-817
40 Ahcan U, Zorman P, Recek D, Ralca S, Majaron B. Port wine stain treatment with a dual-wavelength Nd:Yag laser and cryogen spray cooling: a pilot study. Lasers Surg Med 2004; 34: 164-167
41 Raulin C, Schroeter CA, Weiss RA, Keiner M, Werner S. Treatment of port-wine stains with a noncoherent pulsed light source: a retrospective study. Arch Dermatol 1999; 135: 679-683
42 Babilas P, Schreml S, Eames T, Hohenleutner U, Szeimies RM, Landthaler M. Split-face comparison of intense pulsed light with short- and long-pulsed dye lasers for the treatment of port-wine stains. Lasers Surg Med 2010; 42: 720-727
43 Faurschou A, Togsverd-Bo K, Zachariae C, Haedersdal M. Pulsed dye laser vs. intense pulsed light for port-wine stains: a randomized side-by-side trial with blinded response evaluation. Br J Dermatol 2009; 160: 359-364
44 Bjerring P, Christiansen K, Troilius A. Intense pulsed light source for the treatment of dye laser resistant port-wine stains. J Cosmet Laser Ther 2003; 5: 7-13
45 Orenstein A, Nelson JS, Liaw LH, Kaplan R, Kimel S, Berns MW. Photochemotherapy of hypervascular dermal lesions: a possible alternative to photothermal therapy?. Lasers Surg Med 1990; 10: 334-343
46 Kimel S, Svaasand LO, Kelly KM, Nelson JS. Synergistic photodynamic and photothermal treatment of port-wine stain?. Lasers Surg Med 2004; 34: 80-82
47 Tsoukas MM, Lin GC, Lee MS, Anderson RR, Kollias N. Predictive dosimetry for threshold phototoxicity in photodynamic therapy on normal skin: red wavelengths produce more extensive damage than blue at equal threshold doses. J Invest Dermatol 1997; 108: 501-505
48 Lin GC, Tsoukas ML, Lee MS , et al. Skin necrosis due to photodynamic action of benzoporphyrin depends on circulating rather than tissue drug levels: implications for control of photodynamic therapy. Photochem Photobiol 1998; 68: 575-583
49 Tsoukas MM, González S, Flotte TJ, Anderson RR, Sherwood ME, Kollias N. Wavelength and fluence effect on vascular damage with photodynamic therapy on skin. J Invest Dermatol 2000; 114: 303-308
50 Fingar VH, Kik PK, Haydon PS , et al. Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD). Br J Cancer 1999; 79: 1702-1708
51 Kelly KM, Kimel S, Smith T , et al. Combined photodynamic and photothermal induced injury enhances damage to in vivo model blood vessels. Lasers Surg Med 2004; 34: 407-413
52 Svaasand LO, Norvang LT, Fiskerstrand EJ, Stopps EKS, Berns MW, Nelson JS. Tissue parameters determining the visual appearance of normal skin and port-wine stains. Lasers Med Sci 1995; 10: 55-65
53 Saunders RN, Metcalfe MS, Nicholson ML. Rapamycin in transplantation: a review of the evidence. Kidney Int 2001; 59: 3-16
54 Morice MC, Serruys PW, Sousa JE , et al; RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780
55 Brugarolas JB, Vazquez F, Reddy A, Sellers WR, Kaelin Jr WG. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell 2003; 4: 147-158
56 Mayerhofer M, Valent P, Sperr WR, Griffin JD, Sillaber C. BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin. Blood 2002; 100: 3767-3775
57 Guba M, von Breitenbuch P, Steinbauer M , et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 2002; 8: 128-135
58 Kwon YS, Hong HS, Kim JC, Shin JS, Son Y. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo. Invest Ophthalmol Vis Sci 2005; 46: 454-460
59 Kourembanas S, Hannan RL, Faller DV. Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. J Clin Invest 1990; 86: 670-674
60 Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-845
61 Nelson JS, Jia W, Phung TL, Mihm Jr MC. Observations on enhanced port wine stain blanching induced by combined pulsed dye laser and rapamycin administration. Lasers Surg Med 2011; 43: 939-942
62 Phung TL, Oble DA, Jia W, Benjamin LE, Mihm Jr MC, Nelson JS. Can the wound healing response of human skin be modulated after laser treatment and the effects of exposure extended? Implications on the combined use of the pulsed dye laser and a topical angiogenesis inhibitor for treatment of port wine stain birthmarks. Lasers Surg Med 2008; 40: 1-5
63 Jia W, Sun V, Tran N , et al. Long-term blood vessel removal with combined laser and topical rapamycin antiangiogenic therapy: implications for effective port wine stain treatment. Lasers Surg Med 2010; 42: 105-112
64 Loewe R, Oble DA, Valero T, Zukerberg L, Mihm Jr MC, Nelson JS. Stem cell marker upregulation in normal cutaneous vessels following pulsed-dye laser exposure and its abrogation by concurrent rapamycin administration: implications for treatment of port-wine stain birthmarks. J Cutan Pathol 2010; 37 (Suppl. 01) 76-82
65 Tremaine AM, Armstrong J, Huang YC , et al. Enhanced port-wine stain lightening achieved with combined treatment of selective photothermolysis and imiquimod. J Am Acad Dermatol 2012; 66: 634-641